Rocket Health sets sights on Africa expansion

Uganda's telemedicine company, Rocket Health, has set its sights on expanding into the West African market after securing a $5 million Series A funding. In an exclusive interview with CNBC Africa, Dr. Davis Musinguzi, the Managing Director of Medical Concierge at Rocket Health, discussed the company's growth trajectory and future plans for expansion. Rocket Health is currently focusing on consolidating their presence in East Africa, particularly in Uganda and Kenya, before venturing into the West African market. Dr. Musinguzi highlighted the opportunities for outpatient healthcare, remote doctor consultations, and last-mile delivery of healthcare services in the region. The company's innovative approach to telemedicine and integrated healthcare services has attracted significant investor interest and positioned them for further growth and impact in the healthcare sector. Rocket Health's unique business model, which includes pharmaceutical and laboratory services, sets them apart from competitors and enables them to deliver cost-effective and high-quality healthcare solutions to a wide range of patients. By leveraging technology and operational excellence, Rocket Health has experienced exponential growth, particularly during the COVID-19 pandemic. The company's revenue streams are diversified, with pharmaceutical services, laboratory tests, and clinic visits driving a significant portion of their income. As Rocket Health continues to expand and innovate, they are exploring new funding avenues, including the possibility of crowdfunding, to engage their customers as investors and fuel their pan-African expansion. With a strong focus on customer service, operational efficiency, and local market insights, Rocket Health is poised to become a leading digital healthcare provider in Africa, delivering convenient and accessible healthcare solutions to communities across the continent.